Brain tumor-polyposis syndrome: two genetic diseases?

Area of Science:

• Genetics
• Oncology
• Neurology

Background:

• Turcot’s syndrome, also known as brain tumor-polyposis (BTP), is a rare genetic disorder.
• It is characterized by the co-occurrence of brain tumors and colorectal polyps/cancer.
• Previous classifications have not fully elucidated the distinct genetic underpinnings and clinical presentations.

Purpose of the Study:

• To conduct a comprehensive statistical analysis of brain tumor-polyposis (BTP) cases.
• To differentiate between distinct clinical entities within Turcot’s syndrome.
• To investigate the genetic basis and associated neoplasms in different BTP patient groups.

Main Methods:

• Statistical analysis of clinical and pathological data from BTP patients.
• Phenotypic classification based on polyp type, cancer presence, brain neoplasm type, skin lesions, cafe-au-lait spots, and consanguinity.
• Genetic analysis focusing on DNA replication errors and APC gene mutations.

Main Results:

• BTP patients were classified into two statistically distinct groups (P < .0001).
• Type 1: Glioma with colorectal adenomas (non-FAP), showing early onset (<20 years) and DNA replication errors, suggesting a link to hereditary nonpolyposis colorectal cancer (HNPCC).
• Type 2: CNS tumors within familial adenomatous polyposis (FAP) kindreds (FAP cases), associated with APC gene mutations and an increased incidence of medulloblastoma.

Conclusions:

• Turcot’s syndrome represents at least two distinct genetic entities.
• BTP syndrome type 1 is associated with DNA mismatch repair gene defects, similar to HNPCC.
• BTP syndrome type 2 is linked to APC gene mutations, characteristic of FAP, and may predispose to medulloblastoma.